33 completed, 23 unknown, 2 not yet recruiting, 2 withdrawn. 21 Not applicable, 17 Phase 1, 15 Phase 2, 5 Phase 3, 2 Phase 4.
Follow Amphetamine-Related Disorders: new trials by email Literature Review of Amphetamine-Related Disorders trials Research Report on Amphetamine-Related Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin Therapy for Methamphetamine Use Disorder and HIV Psilocybin 5 mg, Psilocybin 25 mg, Motivational Support - Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV) | Phase 2 | Not yet recruiting | Nicky Mehtani, MD, MPH | 30 | 2026-11-01 | 2026-08-11 |
| Effects of Repetitive Transcranial Magnetic Stimulations in Patients With Amphetamine Use Disorders repetitive Transcranial Magnetic Stimulation (rTMS), sham for repetitive Transcranial Magnetic Stimulation - Amphetamine Use Disorders, Amphetamine Use Disorder | Not applicable | Not yet recruiting | TsaoTun Psychiatric Center, Department of Health, Taiwan | 20 | 2025-05-15 | 2025-05-07 |
| Treatment Effect of Cross-frequency Transcranial Alternating Current Stimulation on the MUD Cross-frequency transcranial alternating current stimulation via the Neuroelectrics Starstim 32 transcranial electric stimulation device - Amphetamine-Related Disorders | Not applicable | Unknown | Shanghai Mental Health Center | 32 | 2023-10-15 | 2023-12-08 |
| Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder Intermittent theta burst transcranial magnetic stimulation (iTBS), Sham stimulation - Craving, Depression, Anxiety | Not applicable | Unknown | National Taiwan University Hospital Hsin-Chu Branch | 60 | 2022-09-01 | 2022-09-10 |
| Hospital-Based Contingency Management Mobile-app based contingency management - Amphetamine-Related Disorders | Not applicable | Unknown | Oregon Health and Science University | 90 | 2022-08-22 | 2024-05-08 |
| Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder Psilocybin, Treatment-as-usual - Amphetamine-Related Disorders | Phase 1 / Phase 2 | Active not recruiting | Portland VA Research Foundation, Inc | 30 | 2022-07-07 | 2026-04-22 |
| Repetitive Transcranial Magnetic Stimulation in Amphetamine Addiction transcranial magnetic stimulation (TMS) - Craving, Depression, Anxiety | Not applicable | Completed | National Taiwan University Hospital | 5 | 2022-02-17 | 2023-03-30 |
| Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: PRE-FAIR Prevention Adaptation of Families Actively Improving Relationships (PRE-FAIR), Standard Case Management and Referral - Opioid-Related Disorders, Stimulant-Related Disorder | Not applicable | Completed | Chestnut Health Systems | 241 | 2021-06-09 | 2026-06-05 |
| Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders. robot-assisted rehabilitation intelligent treatment, standard psychotherapy treatment - Amphetamine Addiction | Not applicable | Unknown | Shanghai Mental Health Center | 200 | 2020-12-01 | 2022-12-29 |
| Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction Dextromethorphan, Memantine, Dextromethorphan and memantine - Amphetamine Addiction, Pharmacotherapy | Phase 2 / Phase 3 | Unknown | National Cheng-Kung University Hospital | 120 | 2020-08-11 | 2020-12-29 |
| Implementation and Effectiveness of Multidiscipline-Integrated Addiction Treatment Model cognitive-behavior group therapy, Individual supportive psychotherapy - Amphetamine-Related Disorders | Not applicable | Unknown | National Health Research Institutes, Taiwan | 48 | 2020-02-24 | 2020-04-01 |
| Computerized Exercise to Alter Stimulant Approach Responses Active CEASAR Intervention, Placebo CEASAR - Amphetamine-Related Disorders, Cocaine-Related Disorders | Not applicable | Unknown | University of British Columbia | 60 | 2018-06-11 | 2021-06-21 |
| The Application of Music Therapy in Female Amphetamine Use Disorder Music therapy group - Amphetamine Addiction | Not applicable | Completed | Shanghai Mental Health Center | 40 | 2017-11-30 | 2018-11-20 |
| The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants Addiction cognitive function rehabilitation and bias modification - Amphetamine Addiction | Not applicable | Completed | Shanghai Mental Health Center | 40 | 2017-10-20 | 2020-01-13 |
| The Novel Addiction Assessment Study in Synthetic Drugs Addiction DSM-5 +Virtual reality-based addiction assessment system, Virtual reality-based addiction assessment system - Amphetamine Addiction | Completed | Shanghai Mental Health Center | 1500 | 2016-12-01 | 2020-01-07 | |
| Cannabioids as a New Intervention for Amphetamine Dependence drug administration - Amphetamine Addiction | Phase 2 | Withdrawn | Centre hospitalier de l'Université de Montréal (CHUM) | 2016-11-01 | 2020-10-23 | |
| Novel Intervention for Amphetamine-type Stimulants Addiction repetitive transcranial magnetic stimulation (rTMS), sham repetitive transcranial magnetic stimulation (rTMS) - Amphetamine Addiction | Not applicable | Completed | Shanghai Mental Health Center | 60 | 2016-07-01 | 2019-12-03 |
| Change the Cycle: An RCT to Prevent Injection Initiation Change the Cycle - Substance Abuse, Intravenous, HIV | Not applicable | Completed | University of Southern California | 979 | 2016-06-01 | 2023-03-20 |
| Conflict Between Maternal Autonomy and Child Health in Substance-use Substance-Related Disorders, Alcohol-Related Disorders | Completed | London School of Hygiene and Tropical Medicine | 6 | 2016-05-01 | 2016-09-08 | |
| Mephedrone and Alcohol Interactions in Humans Mephedrone and alcohol, Mephedrone, Alcohol - Amphetamine-Related Disorders, Alcohol-Related Disorders | Phase 1 | Completed | Parc de Salut Mar | 12 | 2014-12-01 | 2015-10-08 |
Showing 20 of 61. Sign in to see all of them.
Substance-Related Disorders (17) · Mood Disorders (6) · Behavior, Addictive (4) · Cocaine-Related Disorders (4) · Heroin Dependence (4) · Depression (3) · Opioid-Related Disorders (3) · Substance Abuse, Intravenous (3) · Alcohol-Related Disorders (2) · Anxiety Disorders (2) · Attention Deficit Disorder with Hyperactivity (2) · Acquired Immunodeficiency Syndrome (1) · Bipolar Disorder (1) · Depressive Disorder, Major (1)
Chemically-Induced Disorders (61) · Mental Disorders (61) · Substance-Related Disorders (44) · Behavior (7) · Narcotic-Related Disorders (6) · Compulsive Behavior (4) · Impulsive Behavior (4) · Behavioral Symptoms (3) · Opioid-Related Disorders (3) · Attention Deficit and Disruptive Behavior Disorders (2) · Blood-Borne Infections (2) · Communicable Diseases (2) · Genital Diseases (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2)
N-Methyl-3,4-methylenedioxyamphetamine (7) · Bupropion (3) · Mirtazapine (3) · Modafinil (3) · Transcranial Magnetic Stimulation (3) · Lisdexamfetamine Dimesylate (2) · Psilocybin (2) · mephedrone (2) · vivitrol (2) · Aripiprazole (1) · Carvedilol (1) · Clonidine (1) · Counseling (1) · Cytidine Diphosphate Choline (1) · Dexfenfluramine (1)
National Institute on Drug Abuse (NIDA) (12) · Shanghai Mental Health Center (7) · University Hospital, Basel, Switzerland (6) · Universiti Sains Malaysia (3) · California Pacific Medical Center Research Institute (2) · Friends Research Institute, Inc. (2) · National Taiwan University Hospital (2) · New River Pharmaceuticals (2) · Parc de Salut Mar (2) · University of California, Los Angeles (2) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Chestnut Health Systems (1) · Creighton University (1) · Hadassah Medical Organization (1) · London School of Hygiene and Tropical Medicine (1)
United States (29) · China (7) · Switzerland (7) · Taiwan (5) · Malaysia (3) · Canada (2) · Spain (2) · Australia (1) · Iceland (1) · Israel (1) · United Kingdom (1)
Matthias E Liechti, MD (6) · Thomas Newton, M.D. (4) · Reese Jones, M.D. (3) · Walter Ling, M.D. (3) · Gantt Galloway, PharmD (2) · Min Zhao, PhD (2) · Vicknasingam Kasinather, PhD (2) · Aviv M Weinstein, Ph.D (1) · Boris B Quednow, Prof (1) · Cathy J Reback, Ph.D. (1) · Chen Cheng-Che, MD,MSc (1) · Cheng-Che Chen, MD, MSc (1) · Ching-Hua Julie Lee, MD., MPH (1) · Chloe Knox (1) · Chris Stauffer, MD (1)
PMID 22700038, PMID 29912955, PMID 19149817, PMID 20565514, PMID 21715530, PMID 21996132, PMID 22574166, PMID 22680280, PMID 23708468, PMID 23857311, PMID 24527254, PMID 24894963, PMID 27186086, PMID 27206266, PMID 29925497, PMID 31825466, PMID 32063845, PMID 41287143
P50DA018185 (2), 1DP2DA066200 (1), 2009 (1), 7UH3DA050193 (1), K23DA023558 (1), P50DA012756 (1), R01DA017407 (1), R01DA031678 (1), R01DA034527 (1), R01DA038965 (1)